Summary by Moomoo AI
Sanyecao Biopharmaceutical Co., Ltd. (the "Company") resubmitted the monthly securities report for the period ended May 31, 2024 on July 17, 2024. The report shows that the Company's statutory/registered share capital and issued shares (excluding treasury shares) remained unchanged during the reporting period, maintaining 2,000,000,000 common shares with a par value of $0.0001 per share and a total amount of $200,000; the total number of issued shares is 1,297,047,429 shares. In addition, the number of share options in the Company's share option plan for pre- and post-listing call option plans remained unchanged, with 1,854,317 and 37,925,004 share options respectively. During the reporting period, no new shares were issued or treasury shares transferred through the exercise of share options, and no options expired. The Company confirms that all issuances of securities or transfers of treasury shares have been authorized by the Board of Directors and comply with the relevant regulations.
